ZA958140B - New peptides with immunomodulatory effects - Google Patents

New peptides with immunomodulatory effects

Info

Publication number
ZA958140B
ZA958140B ZA958140A ZA958140A ZA958140B ZA 958140 B ZA958140 B ZA 958140B ZA 958140 A ZA958140 A ZA 958140A ZA 958140 A ZA958140 A ZA 958140A ZA 958140 B ZA958140 B ZA 958140B
Authority
ZA
South Africa
Prior art keywords
immunomodulatory effects
new peptides
peptides
new
immunomodulatory
Prior art date
Application number
ZA958140A
Other languages
English (en)
Inventor
Hakan Bergstrand
Kostas Karabelas
Bengt Saernstrand
Tomas Eriksson
Magnus Lindvall
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA958140B publication Critical patent/ZA958140B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA958140A 1994-10-14 1995-09-27 New peptides with immunomodulatory effects ZA958140B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides

Publications (1)

Publication Number Publication Date
ZA958140B true ZA958140B (en) 1997-06-27

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958140A ZA958140B (en) 1994-10-14 1995-09-27 New peptides with immunomodulatory effects

Country Status (20)

Country Link
US (2) US6103697A (xx)
EP (1) EP0783519A1 (xx)
JP (1) JPH10507448A (xx)
AU (1) AU705364B2 (xx)
BR (1) BR9509345A (xx)
CA (1) CA2201479A1 (xx)
CZ (1) CZ111997A3 (xx)
EE (1) EE9700087A (xx)
FI (1) FI971499A (xx)
HU (1) HUT77118A (xx)
IL (1) IL115509A0 (xx)
IS (1) IS4459A (xx)
MX (1) MX9702666A (xx)
NO (1) NO971625L (xx)
PL (1) PL319631A1 (xx)
SE (1) SE9403526D0 (xx)
SK (1) SK46797A3 (xx)
TR (1) TR199501255A2 (xx)
WO (1) WO1996011943A1 (xx)
ZA (1) ZA958140B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
CA2250707A1 (en) * 1996-04-12 1997-10-23 Astra Aktiebolag Cysteine-containing or methionine-containing peptides with immunomodulatory effects
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603462D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603467D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
WO1999019347A1 (en) * 1997-10-10 1999-04-22 Astrazeneca Ab Synthetic genes with immunomodulatory effects
AU761083B2 (en) * 1998-06-03 2003-05-29 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
GB2442408B (en) 2005-04-25 2010-06-30 Cadila Pharmaceuticals Ltd Mycobacterium W as an adjuvant
KR101363455B1 (ko) 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
WO1988005783A1 (en) 1987-01-28 1988-08-11 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
FR2622700B1 (fr) 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
EP0341603A3 (en) * 1988-05-09 1990-07-04 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (ja) 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法
ATE178940T1 (de) 1990-09-11 1999-04-15 Inst Child Health Research Klonierung und sequenzierung von dermatophagoiden-antigenen (hausstaubmilben)
WO1993000108A1 (en) * 1991-06-28 1993-01-07 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (ja) 1991-09-17 1997-09-30 アサヒビール株式会社 ダニ主要アレルゲンの製造方法
WO1993008279A1 (en) 1991-10-16 1993-04-29 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
JP3149033B2 (ja) 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンＤｅｒ ｆ ＩＩ中のペプチド
NZ263050A (en) 1993-03-05 1997-11-24 Cytel Corp Compositions of immunogenic peptides with hla-a2.1 binding motifs
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
PT769054E (pt) 1994-07-05 2000-11-30 Steeno Res Group A S Imunoreguladores
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
WO1996011943A1 (en) 1996-04-25
EP0783519A1 (en) 1997-07-16
IL115509A0 (en) 1996-05-14
SE9403526D0 (sv) 1994-10-14
CZ111997A3 (en) 1997-12-17
PL319631A1 (en) 1997-08-18
AU3713395A (en) 1996-05-06
SK46797A3 (en) 1997-09-10
IS4459A (is) 1997-04-08
AU705364B2 (en) 1999-05-20
NO971625L (no) 1997-05-30
TR199501255A2 (tr) 1996-06-21
BR9509345A (pt) 1997-11-25
JPH10507448A (ja) 1998-07-21
CA2201479A1 (en) 1996-04-25
NO971625D0 (no) 1997-04-09
HUT77118A (hu) 1998-03-02
MX9702666A (es) 1997-06-28
FI971499A0 (fi) 1997-04-10
US6228374B1 (en) 2001-05-08
EE9700087A (et) 1997-10-15
US6103697A (en) 2000-08-15
FI971499A (fi) 1997-06-10

Similar Documents

Publication Publication Date Title
GB2269176B (en) Peptides
EP0793502A4 (en) NEW POLYPEPTIDES DERIVED FROM HEDGEHOG
IL115509A0 (en) New peptides with immunomodulatory effects
EP0765165A4 (en) PREVENTED PEPTIDES
IL108169A0 (en) New peptides
PL318017A1 (en) Peptides
GB9425582D0 (en) Peptides having immunomodulatory activity
ZA962345B (en) New peptides with immunomodulatory effects
AU2131195A (en) Prophenins - antibiotic peptides
EP0746565A4 (en) PEPTIDES RELATED TO BOMBESIN
IL108353A0 (en) Novel peptides
GB9425380D0 (en) Peptides
IL115317A0 (en) Proteins
GB9413751D0 (en) Immunodominant peptides
AUPM489194A0 (en) Peptides
GB9405352D0 (en) Henry
GB9425381D0 (en) Peptides
GB9519511D0 (en) Peptides
GB9613705D0 (en) Novel peptides
GB9421180D0 (en) Immunomodulatory Polypeptides
ZA956331B (en) Peptides
GB9421408D0 (en) Peptides
GB9411049D0 (en) Peptide
SG55039A1 (en) Peptides
GB9605904D0 (en) Peptides